Table 2.
Treatment | Mizuna | Kohlrabi | Kohlrabi | |||
---|---|---|---|---|---|---|
AscA | β-Car | AscA | β-Car | AscA | β-Car | |
BR | 21.1b | 0.57c | 106.4b | 0.58a | 35.0d | 0.44a |
BRG | 20.2bc | 1.26a | 123.0a | 0.39b | 49.9b | 0.30b |
BRY | 16.7c | 1.17a | 29.1d | 0.01c | 54.3a | 0.08c |
BRO | 57.7a | 1.00b | 85.4c | 0.40b | 44.0c | 0.09c |
BR—blue (447 nm), red (638 and 665 nm), far-red (731 nm); BRG—BR with supplemental green (520 nm); BRY—BR with supplemental yellow (595 nm); BRO—BR with supplemental orange (622 nm). Total PPFD maintained at 300 µmol m-2 s-1, changing the input of red 665 nm. The data were processed using one-way analysis of variance (ANOVA), Duncan’s multiple range test at the confidence level p = 0.05. Presented values marked by similar letters do not differ significantly. Samples were taken from the central vessel part, and one vessel represented one replicate, three biological replicates were performed (n = 3). BR, blue-red; BRG, blue-red-green; BRY, blue-red yellow; and BRO, blue-red-orange.